• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

具有激酶结构域的新型癌基因(NOK)的跨膜螺旋影响其寡聚化,并限制RAS/MAPK信号通路的激活。

Transmembrane helix of novel oncogene with kinase-domain (NOK) influences its oligomerization and limits the activation of RAS/MAPK signaling.

作者信息

Li Ying-Hua, Wang Yin-Yin, Zhong Shan, Rong Zhi-Li, Ren Yong-Ming, Li Zhi-Yong, Zhang Shu-Ping, Chang Zhi-Jie, Liu Li

机构信息

Institute of Biomedicine and School of Medicine, Tsinghua University, Beijing, 100084, China.

出版信息

Mol Cells. 2009 Jan 31;27(1):39-45. doi: 10.1007/s10059-009-0003-5. Epub 2009 Feb 5.

DOI:10.1007/s10059-009-0003-5
PMID:19214432
Abstract

Ligand-dependent or independent oligomerization of receptor protein tyrosine kinase (RPTK) is often an essential step for receptor activation and intracellular signaling. The novel oncogene with kinase-domain (NOK) is a unique RPTK that almost completely lacks an ectodomain, expresses intracellularly and activates constitutively. However, it is unknown whether NOK can form oligomer or what function oligomerization would have. In this study, two NOK deletion mutants were generated by either removing the ectodomain (NOKDeltaECD) or including the endodomain (NOK-ICD). Co-immunoprecipitation demonstrated that the transmembrane (TM) domain of NOK was essential for its intermolecular interaction. The results further showed that NOK aggregated more closely as lower order oligomers (the dimer- and trimer-sized) than either deletion mutant did since NOK could be cross-linked by both Sulfo-EGS and formaldehyde, whereas either deletion mutant was only sensitive to Sulfo-EGS. Removing the NOK TM domain (NOK-ICD) not only markedly promoted higher order oligomerization, but also altered the subcellular localization of NOK and dramatically elevated the NOK-mediated constitutive activation of extracellular signal-regulated kinase (ERK). Moreover, NOK-ICD but not NOK or NOKDeltaECD was co-localized with the upstream signaling molecule RAS on cell membrane. Thus, TM-mediated intermolecular contacting may be mainly responsible for the constitutive activation of NOK and contribute to the autoinhibitory effect on RAS/MAPK signaling.

摘要

受体蛋白酪氨酸激酶(RPTK)的配体依赖性或非依赖性寡聚化通常是受体激活和细胞内信号传导的关键步骤。新型激酶结构域癌基因(NOK)是一种独特的RPTK,几乎完全缺乏胞外结构域,在细胞内表达并组成性激活。然而,尚不清楚NOK是否能形成寡聚体,以及寡聚化会有什么功能。在本研究中,通过去除胞外结构域(NOKDeltaECD)或包含胞内结构域(NOK-ICD)产生了两种NOK缺失突变体。免疫共沉淀表明NOK的跨膜(TM)结构域对其分子间相互作用至关重要。结果进一步表明,与任何一种缺失突变体相比,NOK以更低阶的寡聚体(二聚体和三聚体大小)更紧密地聚集,因为NOK可被磺基-EGS和甲醛交联,而任何一种缺失突变体仅对磺基-EGS敏感。去除NOK的TM结构域(NOK-ICD)不仅显著促进了高阶寡聚化,还改变了NOK的亚细胞定位,并显著提高了NOK介导的细胞外信号调节激酶(ERK)的组成性激活。此外,NOK-ICD而非NOK或NOKDeltaECD与上游信号分子RAS在细胞膜上共定位。因此,TM介导的分子间接触可能是NOK组成性激活的主要原因,并有助于对RAS/MAPK信号传导的自抑制作用。

相似文献

1
Transmembrane helix of novel oncogene with kinase-domain (NOK) influences its oligomerization and limits the activation of RAS/MAPK signaling.具有激酶结构域的新型癌基因(NOK)的跨膜螺旋影响其寡聚化,并限制RAS/MAPK信号通路的激活。
Mol Cells. 2009 Jan 31;27(1):39-45. doi: 10.1007/s10059-009-0003-5. Epub 2009 Feb 5.
2
Downregulation of the Ras-mitogen-activated protein kinase pathway by the EphB2 receptor tyrosine kinase is required for ephrin-induced neurite retraction.Ephrin诱导的神经突回缩需要EphB2受体酪氨酸激酶对Ras-丝裂原活化蛋白激酶途径进行下调。
Mol Cell Biol. 2001 Nov;21(21):7429-41. doi: 10.1128/MCB.21.21.7429-7441.2001.
3
The carboxyl terminal tyrosine 417 residue of NOK has an autoinhibitory effect on NOK-mediated signaling transductions.NOK的羧基末端酪氨酸417残基对NOK介导的信号转导具有自抑制作用。
Biochem Biophys Res Commun. 2007 May 4;356(2):444-9. doi: 10.1016/j.bbrc.2007.02.154. Epub 2007 Mar 8.
4
Point mutation at single tyrosine residue of novel oncogene NOK abrogates tumorigenesis in nude mice.新型致癌基因NOK单个酪氨酸残基处的点突变可消除裸鼠体内的肿瘤发生。
Cancer Res. 2005 Dec 1;65(23):10838-46. doi: 10.1158/0008-5472.CAN-05-1091.
5
A novel protein tyrosine kinase NOK that shares homology with platelet- derived growth factor/fibroblast growth factor receptors induces tumorigenesis and metastasis in nude mice.一种与血小板衍生生长因子/成纤维细胞生长因子受体具有同源性的新型蛋白酪氨酸激酶NOK可在裸鼠中诱导肿瘤发生和转移。
Cancer Res. 2004 May 15;64(10):3491-9. doi: 10.1158/0008-5472.CAN-03-2106.
6
Mammalian Sprouty4 suppresses Ras-independent ERK activation by binding to Raf1.哺乳动物的Sprouty4通过与Raf1结合来抑制不依赖Ras的细胞外信号调节激酶(ERK)激活。
Nat Cell Biol. 2003 May;5(5):427-32. doi: 10.1038/ncb978.
7
The Shb adaptor protein binds to tyrosine 766 in the FGFR-1 and regulates the Ras/MEK/MAPK pathway via FRS2 phosphorylation in endothelial cells.Shb衔接蛋白与FGFR-1中的酪氨酸766结合,并通过内皮细胞中的FRS2磷酸化调节Ras/MEK/MAPK信号通路。
Mol Biol Cell. 2002 Aug;13(8):2881-93. doi: 10.1091/mbc.e02-02-0103.
8
Ras-dependent ERK activation by the human G(s)-coupled serotonin receptors 5-HT4(b) and 5-HT7(a).人G(s)偶联的5-羟色胺受体5-HT4(b)和5-HT7(a)通过Ras依赖的方式激活细胞外信号调节激酶(ERK)
J Biol Chem. 2003 Jan 31;278(5):3098-104. doi: 10.1074/jbc.M206237200. Epub 2002 Nov 21.
9
Constitutive activation of the Ras/MAP kinase pathway and enhanced TCR signaling by targeting the Shc adaptor to membrane rafts.通过将Shc接头蛋白靶向膜筏实现Ras/MAP激酶途径的组成性激活和增强的TCR信号传导。
Oncogene. 2000 Mar 16;19(12):1529-37. doi: 10.1038/sj.onc.1203451.
10
Signaling complexes and protein-protein interactions involved in the activation of the Ras and phosphatidylinositol 3-kinase pathways by the c-Ret receptor tyrosine kinase.c-Ret受体酪氨酸激酶激活Ras和磷脂酰肌醇3-激酶途径所涉及的信号复合物及蛋白质-蛋白质相互作用。
J Biol Chem. 2000 Dec 15;275(50):39159-66. doi: 10.1074/jbc.M006908200.

引用本文的文献

1
Cross-Talk between NOK and EGFR: Juxtamembrane and Kinase domain interactions enhancing STAT3/5 signaling in breast cancer tumorigenesis.NOK与表皮生长因子受体(EGFR)之间的相互作用:近膜区和激酶结构域的相互作用增强乳腺癌肿瘤发生过程中的信号转导和转录激活因子3/5(STAT3/5)信号通路。
Transl Oncol. 2025 Feb;52:102276. doi: 10.1016/j.tranon.2025.102276. Epub 2025 Jan 13.
2
Therapeutic advances of targeting receptor tyrosine kinases in cancer.靶向治疗癌症受体酪氨酸激酶的治疗进展。
Signal Transduct Target Ther. 2024 Aug 14;9(1):201. doi: 10.1038/s41392-024-01899-w.
3
Downregulation of GLUT3 impairs STYK1/NOK-mediated metabolic reprogramming and proliferation in NIH-3T3 cells.
GLUT3的下调会损害STYK1/NOK介导的NIH-3T3细胞代谢重编程和增殖。
Oncol Lett. 2021 Jul;22(1):527. doi: 10.3892/ol.2021.12788. Epub 2021 May 14.
4
STYK1 promotes autophagy through enhancing the assembly of autophagy-specific class III phosphatidylinositol 3-kinase complex I.STYK1 通过增强自噬特异性 III 类磷酸肌醇 3-激酶复合物 I 的组装来促进自噬。
Autophagy. 2020 Oct;16(10):1786-1806. doi: 10.1080/15548627.2019.1687212. Epub 2019 Nov 7.
5
Depletion of STYK1 inhibits intrahepatic cholangiocarcinoma development both in vitro and in vivo.STYK1 的缺失在体外和体内均抑制肝内胆管癌的发展。
Tumour Biol. 2016 Oct;37(10):14173-14181. doi: 10.1007/s13277-016-5188-6. Epub 2016 Aug 19.
6
Clinicopathologic features and prognostic implications of NOK/STYK1 protein expression in non-small cell lung cancer.非小细胞肺癌中NOK/STYK1蛋白表达的临床病理特征及预后意义
BMC Cancer. 2014 Jun 4;14:402. doi: 10.1186/1471-2407-14-402.
7
Dissection of the dimerization modes in the DJ-1 superfamily.DJ-1 超家族二聚化模式的剖析。
Mol Cells. 2012 Feb;33(2):163-71. doi: 10.1007/s10059-012-2220-6. Epub 2012 Jan 2.
8
LRRK2 in Parkinson's disease: function in cells and neurodegeneration.LRRK2 在帕金森病中的作用:细胞与神经退行性变。
FEBS J. 2009 Nov;276(22):6436-44. doi: 10.1111/j.1742-4658.2009.07342.x. Epub 2009 Oct 5.